(WW) WW International, Common - Overview
Stock: Digital Subscriptions, Nutritional Tools, Lifestyle Programs, Licensing
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 85.0% |
| Relative Tail Risk | -4.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.04 |
| Alpha | -46.57 |
| Character TTM | |
|---|---|
| Beta | 2.039 |
| Beta Downside | 1.180 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.34% |
| CAGR/Max DD | -0.51 |
Description: WW WW International, Common January 11, 2026
WW International, Inc. (NASDAQ: WW) delivers weight-management solutions across the U.S., Germany, and other markets through a blend of nutritional, activity, behavioral, and lifestyle tools. Its offering includes digital subscriptions that give members personalized coaching via an app and web platform, plus a community component where users share experiences. The firm also monetizes its brand by licensing trademarks for food, beverage, and related consumer products, and provides publishing services. Formerly Weight Watchers, the company rebranded to WW in September 2019 and has operated since 1963 from its New York headquarters.
Key recent metrics: WW reported ~ 5.2 million total members in FY 2023, with digital subscriptions accounting for roughly 70 % of recurring revenue, and a 12 % year-over-year increase in subscription revenue driven by higher engagement with its “WW app.” Macro-level, rising obesity prevalence (≈ 42 % U.S. adult rate) and expanding use of GLP-1 drugs (e.g., semaglutide) create a larger addressable market for weight-loss programs, while discretionary consumer spending trends influence subscription growth. The health-and-wellness sector’s shift toward digital, subscription-based models is a core growth driver for WW.
For a deeper, data-rich assessment of WW’s valuation dynamics, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 1.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA 7.92 > 1.0 |
| NWC/Revenue: 12.01% < 20% (prev -10.93%; Δ 22.94% < -1%) |
| CFO/TA -0.02 > 3% & CFO -21.4m > Net Income 1.09b |
| Net Debt (298.8m) to EBITDA (1.24b): 0.24 < 3 |
| Current Ratio: 1.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (81.2m) vs 12m ago 1.80% < -2% |
| Gross Margin: 71.78% > 18% (prev 0.66%; Δ 7112 % > 0.5%) |
| Asset Turnover: 93.91% > 50% (prev 143.6%; Δ -49.68% > 0%) |
| Interest Coverage Ratio: 15.52 > 6 (EBITDA TTM 1.24b / Interest Expense TTM 77.7m) |
Altman Z'' 10.00
| A: 0.09 (Total Current Assets 219.3m - Total Current Liabilities 133.0m) / Total Assets 968.8m |
| B: -0.06 (Retained Earnings -56.3m / Total Assets 968.8m) |
| C: 1.58 (EBIT TTM 1.21b / Avg Total Assets 765.6m) |
| D: 0.50 (Book Value of Equity 323.0m / Total Liabilities 645.8m) |
| Altman-Z'' Score: 11.51 = AAA |
Beneish M -1.69
| DSRI: 1.33 (Receivables 14.9m/12.6m, Revenue 718.9m/807.5m) |
| GMI: 0.91 (GM 71.78% / 65.57%) |
| AQI: 1.07 (AQ_t 0.76 / AQ_t-1 0.71) |
| SGI: 0.89 (Revenue 718.9m / 807.5m) |
| TATA: 1.14 (NI 1.09b - CFO -21.4m) / TA 968.8m) |
| Beneish M-Score: -1.69 (Cap -4..+1) = CCC |
What is the price of WW shares?
Over the past week, the price has changed by +8.10%, over one month by -35.16%, over three months by -36.31% and over the past year by -18.93%.
Is WW a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.2 | 110.9% |
| Analysts Target Price | 46.2 | 110.9% |
| ValueRay Target Price | 20.8 | -4.8% |
WW Fundamental Data Overview February 02, 2026
P/E Forward = 74.0741
P/S = 0.2762
P/B = 0.6503
P/EG = 4.9212
Revenue TTM = 718.9m USD
EBIT TTM = 1.21b USD
EBITDA TTM = 1.24b USD
Long Term Debt = 465.5m USD (from longTermDebt, last quarter)
Short Term Debt = 1.26m USD (from shortTermDebt, last quarter)
Debt = 468.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 298.8m USD (from netDebt column, last quarter)
Enterprise Value = 501.0m USD (202.2m + Debt 468.9m - CCE 170.1m)
Interest Coverage Ratio = 15.52 (Ebit TTM 1.21b / Interest Expense TTM 77.7m)
EV/FCF = -17.99x (Enterprise Value 501.0m / FCF TTM -27.9m)
FCF Yield = -5.56% (FCF TTM -27.9m / Enterprise Value 501.0m)
FCF Margin = -3.87% (FCF TTM -27.9m / Revenue TTM 718.9m)
Net Margin = 151.0% (Net Income TTM 1.09b / Revenue TTM 718.9m)
Gross Margin = 71.78% ((Revenue TTM 718.9m - Cost of Revenue TTM 202.9m) / Revenue TTM)
Gross Margin QoQ = 72.61% (prev 73.73%)
Tobins Q-Ratio = 0.52 (Enterprise Value 501.0m / Total Assets 968.8m)
Interest Expense / Debt = 2.57% (Interest Expense 12.1m / Debt 468.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 953.2m (EBIT 1.21b * (1 - 21.00%))
Current Ratio = 1.65 (Total Current Assets 219.3m / Total Current Liabilities 133.0m)
Debt / Equity = 1.45 (Debt 468.9m / totalStockholderEquity, last quarter 323.0m)
Debt / EBITDA = 0.24 (Net Debt 298.8m / EBITDA 1.24b)
Debt / FCF = -10.73 (negative FCF - burning cash) (Net Debt 298.8m / FCF TTM -27.9m)
Total Stockholder Equity = -398.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 141.8% (Net Income 1.09b / Total Assets 968.8m)
RoE = -272.6% (negative equity) (Net Income TTM 1.09b / Total Stockholder Equity -398.3m)
RoCE = 1797 % (out of range, set to none) (EBIT 1.21b / Capital Employed (Equity -398.3m + L.T.Debt 465.5m))
RoIC = 160.8% (NOPAT 953.2m / Invested Capital 592.8m)
WACC = 5.47% (E(202.2m)/V(671.2m) * Re(13.43%) + D(468.9m)/V(671.2m) * Rd(2.57%) * (1-Tc(0.21)))
Discount Rate = 13.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.28%
Fair Price DCF = unknown (Cash Flow -27.9m)
EPS Correlation: -8.31 | EPS CAGR: -88.09% | SUE: -4.0 | # QB: 0
Revenue Correlation: -97.42 | Revenue CAGR: -11.98% | SUE: 1.54 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-1.05 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=1
EPS next Year (2026-12-31): EPS=3.38 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+315.3% | Growth Revenue=-9.7%